| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 21 | 0 | 0 | 21 |
| Chain A, HADH2 protein | 21 | 0 | 0 | 21 |
| Chain B, HADH2 protein | 21 | 0 | 0 | 21 |
| RAR-related orphan receptor gamma | 72 | 0 | 0 | 72 |
| GLI family zinc finger 3 | 74 | 0 | 0 | 74 |
| AR protein | 98 | 0 | 0 | 98 |
| aldehyde dehydrogenase 1 family, member A1 | 45 | 0 | 0 | 45 |
| thyroid stimulating hormone receptor | 34 | 0 | 0 | 34 |
| estrogen receptor 2 (ER beta) | 55 | 0 | 0 | 55 |
| nuclear receptor subfamily 1, group I, member 3 | 78 | 0 | 0 | 78 |
| progesterone receptor | 64 | 0 | 0 | 64 |
| glucocorticoid receptor [Homo sapiens] | 63 | 0 | 0 | 63 |
| retinoic acid nuclear receptor alpha variant 1 | 77 | 0 | 0 | 77 |
| estrogen-related nuclear receptor alpha | 84 | 0 | 0 | 84 |
| pregnane X nuclear receptor | 83 | 0 | 0 | 83 |
| estrogen nuclear receptor alpha | 100 | 0 | 0 | 100 |
| aryl hydrocarbon receptor | 55 | 0 | 0 | 55 |
| thyroid stimulating hormone receptor | 45 | 0 | 0 | 45 |
| activating transcription factor 6 | 35 | 0 | 0 | 35 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 46 | 0 | 0 | 46 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 53 | 0 | 0 | 53 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 15 | 0 | 0 | 15 |
| thyroid hormone receptor beta isoform 2 | 74 | 0 | 0 | 74 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 85 | 0 | 0 | 85 |
| cytochrome P450 3A4 isoform 1 | 37 | 0 | 0 | 37 |
| Gamma-aminobutyric acid receptor subunit pi | 37 | 1 | 0 | 38 |
| Voltage-dependent calcium channel gamma-2 subunit | 46 | 0 | 0 | 46 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit delta | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 37 | 1 | 0 | 38 |
| Glutamate receptor 2 | 47 | 0 | 0 | 47 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 37 | 1 | 0 | 38 |
| Kelch-like ECH-associated protein 1 | 0 | 0 | 1 | 1 |
| GABA theta subunit | 37 | 1 | 0 | 38 |
| Gamma-aminobutyric acid receptor subunit epsilon | 37 | 1 | 0 | 38 |
| Histone acetyltransferase KAT8 | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 2 | 0 | 2 |
| Luciferase | 30 | 0 | 0 | 30 |
| interleukin 8 | 11 | 0 | 0 | 11 |
| retinoid X nuclear receptor alpha | 70 | 0 | 0 | 70 |
| farnesoid X nuclear receptor | 62 | 0 | 0 | 62 |
| peroxisome proliferator-activated receptor delta | 50 | 0 | 0 | 50 |
| peroxisome proliferator activated receptor gamma | 59 | 0 | 0 | 59 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 54 | 0 | 0 | 54 |
| Histone H2A.x | 29 | 0 | 0 | 29 |
| heat shock protein beta-1 | 39 | 0 | 0 | 39 |
| mitogen-activated protein kinase 1 | 28 | 0 | 0 | 28 |
| Cellular tumor antigen p53 | 70 | 0 | 0 | 70 |
| Nuclear receptor ROR-gamma | 20 | 0 | 0 | 20 |
| Peroxisome proliferator-activated receptor alpha | 4 | 1 | 1 | 6 |
| ATPase family AAA domain-containing protein 5 | 22 | 0 | 0 | 22 |
| Ataxin-2 | 28 | 0 | 0 | 28 |
| SMAD family member 2 | 31 | 0 | 0 | 31 |
| SMAD family member 3 | 31 | 0 | 0 | 31 |
| histone deacetylase 9 isoform 3 | 13 | 0 | 0 | 13 |
| acetylcholinesterase | 41 | 0 | 0 | 41 |
| hypoxia-inducible factor 1 alpha subunit | 41 | 0 | 0 | 41 |
| Fumarate hydratase | 12 | 0 | 0 | 12 |
| TDP1 protein | 58 | 0 | 0 | 58 |
| caspase 7, apoptosis-related cysteine protease | 16 | 0 | 0 | 16 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 48 | 0 | 0 | 48 |
| cytochrome P450 2D6 | 35 | 0 | 0 | 35 |
| polyprotein | 12 | 0 | 0 | 12 |
| 67.9K protein | 9 | 0 | 0 | 9 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 56 | 0 | 0 | 56 |
| caspase-3 | 16 | 0 | 0 | 16 |
| thyrotropin-releasing hormone receptor | 6 | 0 | 0 | 6 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 31 | 0 | 0 | 31 |
| Interferon beta | 43 | 0 | 0 | 43 |
| Spike glycoprotein | 30 | 1 | 0 | 31 |
| Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 6 | 0 | 0 | 6 |
| Chain A, Ferritin light chain | 13 | 0 | 0 | 13 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 28 | 0 | 0 | 28 |
| phosphopantetheinyl transferase | 17 | 0 | 0 | 17 |
| GLS protein | 14 | 0 | 0 | 14 |
| Smad3 | 9 | 0 | 0 | 9 |
| EWS/FLI fusion protein | 19 | 0 | 0 | 19 |
| arylsulfatase A | 8 | 0 | 0 | 8 |
| euchromatic histone-lysine N-methyltransferase 2 | 43 | 0 | 0 | 43 |
| Bloom syndrome protein isoform 1 | 12 | 0 | 0 | 12 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 6 | 0 | 0 | 6 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 8 | 0 | 0 | 8 |
| lamin isoform A-delta10 | 38 | 0 | 0 | 38 |
| Solute carrier family 22 member 1 | 0 | 8 | 0 | 11 |
| ATP-binding cassette sub-family C member 3 | 0 | 28 | 0 | 28 |
| Multidrug resistance-associated protein 4 | 0 | 28 | 0 | 30 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 12 | 0 | 12 |
| Bile salt export pump | 0 | 48 | 0 | 48 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
| POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 14 | 0 | 15 |
| Cytochrome P450 2J2 | 0 | 9 | 0 | 10 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 8 | 0 | 0 | 8 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 3 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 27 | 0 | 27 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Chain A, Beta-lactamase | 12 | 0 | 0 | 12 |
| glp-1 receptor, partial | 15 | 0 | 0 | 15 |
| ATAD5 protein, partial | 15 | 0 | 0 | 15 |
| IDH1 | 15 | 0 | 0 | 15 |
| nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
| cellular tumor antigen p53 isoform a | 11 | 0 | 0 | 11 |
| chromobox protein homolog 1 | 29 | 0 | 0 | 29 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 14 | 0 | 0 | 14 |
| transcriptional regulator ERG isoform 3 | 9 | 0 | 0 | 9 |
| urokinase-type plasminogen activator precursor | 9 | 0 | 0 | 9 |
| plasminogen precursor | 9 | 0 | 0 | 9 |
| urokinase plasminogen activator surface receptor precursor | 9 | 0 | 0 | 9 |
| geminin | 48 | 0 | 0 | 48 |
| Vif | 0 | 1 | 0 | 2 |
| peripheral myelin protein 22 | 33 | 0 | 0 | 33 |
| survival motor neuron protein isoform d | 18 | 0 | 0 | 18 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 2 | 0 | 3 |
| neuropeptide S receptor isoform A | 9 | 0 | 0 | 9 |
| Integrin beta-3 | 9 | 0 | 0 | 9 |
| Integrin alpha-IIb | 9 | 0 | 0 | 9 |
| Methionine aminopeptidase | 0 | 2 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 14 | 0 | 0 | 14 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 1 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 5 | 6 |
| Procathepsin L | 0 | 2 | 0 | 2 |
| Cathepsin B | 0 | 2 | 0 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 6 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| Mitochondrial 2-oxodicarboxylate carrier | 0 | 1 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 34 | 0 | 0 | 34 |
| Alpha-2A adrenergic receptor | 0 | 17 | 0 | 17 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 21 | 0 | 0 | 21 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 19 | 0 | 0 | 19 |
| 5-hydroxytryptamine receptor 3E | 0 | 4 | 0 | 4 |
| USP1 protein, partial | 24 | 0 | 0 | 24 |
| PPM1D protein | 8 | 0 | 0 | 8 |
| Microtubule-associated protein tau | 18 | 0 | 0 | 18 |
| G | 37 | 0 | 0 | 37 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 6 | 0 | 0 | 6 |
| lysosomal alpha-glucosidase preproprotein | 6 | 0 | 0 | 6 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 22 | 0 | 0 | 22 |
| histone acetyltransferase KAT2A isoform 1 | 16 | 0 | 0 | 16 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
| Solute carrier family 22 member 2 | 0 | 6 | 0 | 7 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 4 | 0 | 4 |
| HLA class I histocompatibility antigen, B alpha chain | 37 | 0 | 0 | 37 |
| ATP-dependent translocase ABCB1 | 0 | 8 | 0 | 12 |
| Cytochrome P450 3A4 | 0 | 15 | 1 | 19 |
| 5-hydroxytryptamine receptor 1A | 0 | 8 | 4 | 12 |
| 5-hydroxytryptamine receptor 2C | 0 | 15 | 0 | 15 |
| Neuronal acetylcholine receptor subunit alpha-4 | 2 | 2 | 2 | 7 |
| Neuronal acetylcholine receptor subunit beta-2 | 2 | 2 | 2 | 7 |
| D(2) dopamine receptor | 0 | 19 | 4 | 29 |
| 5-hydroxytryptamine receptor 2A | 0 | 15 | 0 | 15 |
| Alpha-1B adrenergic receptor | 0 | 19 | 1 | 20 |
| Alpha-2C adrenergic receptor | 0 | 13 | 0 | 13 |
| D | 0 | 12 | 0 | 12 |
| 5-hydroxytryptamine receptor 1A | 0 | 13 | 0 | 13 |
| Muscarinic acetylcholine receptor M3 | 0 | 12 | 1 | 13 |
| D(1A) dopamine receptor | 0 | 11 | 0 | 13 |
| D(4) dopamine receptor | 0 | 11 | 1 | 16 |
| D(1B) dopamine receptor | 0 | 4 | 0 | 6 |
| Alpha-1D adrenergic receptor | 0 | 15 | 1 | 16 |
| Alpha-1D adrenergic receptor | 0 | 11 | 0 | 11 |
| 5-hydroxytryptamine receptor 2A | 0 | 17 | 0 | 19 |
| 5-hydroxytryptamine receptor 2C | 0 | 17 | 1 | 18 |
| D(4) dopamine receptor | 0 | 10 | 0 | 10 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 23 | 4 | 27 |
| 5-hydroxytryptamine receptor 7 | 0 | 7 | 0 | 7 |
| 5-hydroxytryptamine receptor 7 | 0 | 8 | 0 | 8 |
| Alpha-1A adrenergic receptor | 0 | 7 | 0 | 7 |
| Histamine H1 receptor | 0 | 14 | 3 | 19 |
| Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
| D(3) dopamine receptor | 0 | 14 | 3 | 23 |
| 5-hydroxytryptamine receptor 2B | 0 | 16 | 1 | 17 |
| Alpha-1A adrenergic receptor | 0 | 19 | 1 | 20 |
| 5-hydroxytryptamine receptor 3A | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 6 | 0 | 15 | 0 | 16 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 4 | 0 | 4 |
| D(2) dopamine receptor | 0 | 18 | 0 | 18 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 24 | 0 | 24 |
| 5-hydroxytryptamine receptor 3D | 0 | 4 | 0 | 4 |
| Multidrug and toxin extrusion protein 2 | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 3C | 0 | 4 | 0 | 4 |
| Inositol hexakisphosphate kinase 1 | 37 | 0 | 0 | 37 |
| Multidrug and toxin extrusion protein 1 | 0 | 8 | 0 | 8 |
| Histamine H3 receptor | 0 | 5 | 0 | 5 |
| cytochrome P450 2C9, partial | 37 | 0 | 0 | 37 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 14 | 0 | 0 | 14 |
| Polyphenol oxidase 2 | 0 | 5 | 0 | 6 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 2 |
| Urease | 0 | 2 | 0 | 2 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 16 | 1 | 17 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| pregnane X receptor | 33 | 0 | 0 | 33 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 11 | 0 | 0 | 11 |
| 60 kDa chaperonin | 0 | 4 | 0 | 4 |
| 60 kDa heat shock protein, mitochondrial | 0 | 5 | 0 | 5 |
| 10 kDa heat shock protein, mitochondrial | 0 | 5 | 0 | 5 |
| Thiosulfate sulfurtransferase | 0 | 5 | 0 | 5 |
| 60 kDa chaperonin | 0 | 5 | 0 | 5 |
| 10 kDa chaperonin | 0 | 5 | 0 | 5 |
| vitamin D3 receptor isoform VDRA | 26 | 0 | 0 | 26 |
| kallikrein-5 preproprotein | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 6 | 0 | 7 |
| Guanine nucleotide-binding protein G | 6 | 0 | 0 | 6 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 8 | 0 | 0 | 8 |
| Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 12 | 0 | 0 | 12 |
| Carbonic anhydrase 12 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase 1 | 0 | 15 | 0 | 17 |
| Carbonic anhydrase 2 | 0 | 15 | 1 | 18 |
| Carbonic anhydrase 3 | 0 | 5 | 0 | 5 |
| Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 9 | 0 | 10 |
| Carbonic anhydrase 6 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 6 | 1 | 8 |
| Carbonic anhydrase 7 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase 9 | 0 | 5 | 0 | 7 |
| Carbonic anhydrase 13 | 0 | 3 | 0 | 3 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 5 | 0 | 6 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 10 | 0 | 0 | 10 |
| Caspase-7 | 10 | 0 | 0 | 10 |
| caspase-3 | 10 | 0 | 0 | 10 |
| Androgen receptor | 0 | 10 | 0 | 10 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 2 | 2 |
| Chain A, Cruzipain | 10 | 0 | 0 | 10 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| PAX8 | 0 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 17 | 0 | 0 | 17 |
| PINK1 | 4 | 0 | 0 | 4 |
| glucocerebrosidase | 8 | 0 | 0 | 8 |
| Parkin | 4 | 0 | 0 | 4 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | 11 | 0 | 0 | 11 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C19 precursor | 10 | 0 | 0 | 10 |
| cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
| perilipin-5 | 0 | 3 | 0 | 3 |
| perilipin-1 | 0 | 3 | 0 | 3 |
| huntingtin isoform 2 | 6 | 0 | 0 | 6 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| flap endonuclease 1 | 10 | 0 | 0 | 10 |
| protein AF-9 isoform a | 0 | 0 | 0 | 2 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 3 | 0 | 3 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 2 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 2 | 2 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 9 | 0 | 0 | 9 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 3 | 0 | 3 |
| Glutathione reductase, mitochondrial | 0 | 3 | 0 | 5 |
| 72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 5 | 4 | 0 | 9 |
| Histamine H2 receptor | 12 | 1 | 0 | 14 |
| TAR DNA-binding protein 43 | 13 | 0 | 0 | 13 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 5 | 0 | 0 | 5 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 6 | 0 | 6 |
| Carbonic anhydrase 15 | 0 | 7 | 0 | 7 |
| bromodomain adjacent to zinc finger domain 2B | 10 | 0 | 0 | 10 |
| serine-protein kinase ATM isoform a | 4 | 0 | 0 | 4 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 8 | 0 | 0 | 8 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| ORF73 | 0 | 0 | 1 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 7 | 0 | 0 | 7 |
| D(1A) dopamine receptor | 11 | 0 | 0 | 11 |
| Sodium-dependent noradrenaline transporter | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 14 | 0 | 14 |
| Aldo-keto reductase family 1 member B1 | 0 | 12 | 0 | 12 |
| Tryptophan 5-hydroxylase 1 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 12 | 0 | 12 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 11 | 2 | 15 |
| Aromatase | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 17 | 3 | 20 |
| Sodium-dependent dopamine transporter | 0 | 12 | 0 | 12 |
| Sodium-dependent serotonin transporter | 0 | 11 | 0 | 12 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 13 | 2 | 15 |
| Sigma intracellular receptor 2 | 0 | 5 | 0 | 5 |
| Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 5 | 0 | 5 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 11 | 0 | 11 |
| Sigma non-opioid intracellular receptor 1 | 0 | 14 | 0 | 14 |
| Sigma non-opioid intracellular receptor 1 | 0 | 9 | 0 | 9 |
| Transporter | 0 | 12 | 1 | 14 |
| ATP-dependent phosphofructokinase | 17 | 0 | 0 | 17 |
| glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| SUMO-1 | 0 | 1 | 0 | 1 |
| TSHR protein | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 17 | 0 | 0 | 17 |
| hexokinase | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 5 | 0 | 0 | 5 |
| DNA polymerase eta isoform 1 | 5 | 0 | 0 | 5 |
| DNA polymerase iota isoform a (long) | 14 | 0 | 0 | 14 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Long-chain-fatty-acid--AMP ligase FadD32 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 5 | 0 | 0 | 5 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Sporulation initiation phosphotransferase F | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 4 | 0 | 4 |
| Sporulation kinase A | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Chitinase | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 3 | 0 | 3 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Efflux transporter | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 2 |
| NFKB1 protein, partial | 7 | 0 | 0 | 7 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 7 | 0 | 0 | 7 |
| DNA polymerase beta | 7 | 0 | 0 | 7 |
| atrial natriuretic peptide receptor 2 precursor | 6 | 0 | 0 | 6 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| M-phase phosphoprotein 8 | 9 | 0 | 0 | 9 |
| transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 10 | 0 | 0 | 10 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 8 | 0 | 8 |
| Albumin | 0 | 0 | 5 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 10 | 1 | 11 |
| Muscarinic acetylcholine receptor M4 | 0 | 10 | 1 | 11 |
| Muscarinic acetylcholine receptor M1 | 0 | 8 | 1 | 9 |
| Muscarinic acetylcholine receptor M3 | 0 | 7 | 1 | 8 |
| Muscarinic acetylcholine receptor M4 | 0 | 8 | 1 | 9 |
| Muscarinic acetylcholine receptor M5 | 0 | 8 | 1 | 9 |
| Muscarinic acetylcholine receptor M5 | 0 | 13 | 0 | 13 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 4 | 0 | 4 |
| Cytochrome P450 2D6 | 0 | 6 | 0 | 7 |
| Muscarinic acetylcholine receptor M2 | 0 | 8 | 1 | 9 |
| Muscarinic acetylcholine receptor M1 | 0 | 12 | 3 | 16 |
| Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 10 | 0 | 10 |
| Alpha-2B adrenergic receptor | 0 | 9 | 1 | 10 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| Endothelin receptor type B | 2 | 1 | 0 | 3 |
| Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 9 | 1 | 10 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 9 | 1 | 10 |
| 5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
| Endothelin receptor type B | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 6 | 0 | 6 |
| Adenosine receptor A1 | 0 | 3 | 0 | 3 |
| D(1B) dopamine receptor | 0 | 8 | 0 | 8 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 7 | 0 | 7 |
| 5-hydroxytryptamine receptor 1D | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1F | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 2B | 0 | 14 | 1 | 15 |
| Histamine H1 receptor | 0 | 5 | 0 | 5 |
| Cytochrome P450 2C19 | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 8 | 0 | 8 |
| 5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 8 | 0 | 8 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 8 | 0 | 8 |
| Transporter | 0 | 5 | 0 | 5 |
| Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
| D | 0 | 3 | 0 | 3 |
| Histamine H4 receptor | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
| Amyloid-beta precursor protein | 1 | 4 | 0 | 6 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 1 | 4 |
| Liver carboxylesterase 1 | 0 | 2 | 0 | 3 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 5B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 0 | 5 |
| Lysosomal Pro-X carboxypeptidase | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 0 | 5 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 6 | 0 | 6 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 0 | 6 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
| Leukotriene B4 receptor 1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
| Leukotriene B4 receptor 2 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
| GALC protein | 6 | 0 | 0 | 6 |
| Thrombopoietin | 4 | 0 | 0 | 4 |
| nonstructural protein 1 | 9 | 0 | 0 | 9 |
| serine/threonine-protein kinase mTOR isoform 1 | 8 | 0 | 0 | 8 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 3 | 3 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
| C-8 sterol isomerase | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 3 | 0 | 3 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 2 | 0 | 4 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 14 | 0 | 0 | 14 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
| Chain A, Odorant binding protein | 0 | 0 | 1 | 1 |
| Chain B, Odorant binding protein | 0 | 0 | 1 | 1 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| NAD | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 6 | 0 | 6 |
| NAD | 0 | 1 | 0 | 2 |
| ATP phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 2 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Integrase | 0 | 2 | 0 | 2 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| DNA polymerase beta | 0 | 1 | 0 | 1 |
| Furin | 0 | 1 | 0 | 1 |
| Amiloride-sensitive amine oxidase [copper-containing] | 0 | 1 | 0 | 1 |
| Diamine acetyltransferase 1 | 0 | 1 | 0 | 1 |
| Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
| Acid-sensing ion channel 2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
| Prostacyclin receptor | 0 | 2 | 1 | 3 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 6 | 0 | 0 | 6 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| pyruvate kinase | 4 | 0 | 0 | 4 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 2 | 0 | 2 |
| LacZ protein (plasmid) | 0 | 0 | 1 | 1 |
| Spike glycoprotein | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 2 | 0 | 2 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| polypyrimidine tract-binding protein 1 isoform a | 1 | 0 | 0 | 1 |
| apelin receptor | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 2 | 0 | 4 |
| Vpr | 4 | 0 | 0 | 4 |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 1 | 0 | 1 |
| Carbamate kinase | 0 | 1 | 0 | 1 |
| Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Aldehyde dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 5 | 0 | 6 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
| Amine oxidase [flavin-containing] A | 0 | 8 | 0 | 8 |
| C-X-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
| Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
| Caspase-1 | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 6 | 2 | 8 |
| Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
| C-C chemokine receptor type 5 | 0 | 2 | 0 | 2 |
| Gasdermin-D | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| Monoglyceride lipase | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 0 | 1 |
| Gasdermin-D | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 2 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 2 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 2 |
| large T antigen | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 1 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] B | 0 | 6 | 0 | 6 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 5 | 0 | 6 |
| Cholinesterase | 0 | 3 | 0 | 3 |
| Acetylcholine receptor subunit epsilon | 0 | 1 | 1 | 2 |
| Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 2 | 0 | 2 |
| Carboxylic ester hydrolase | 0 | 2 | 0 | 2 |
| Carboxylic ester hydrolase | 0 | 3 | 0 | 3 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 6 | 1 | 7 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 0 | 1 |
| NADH-ubiquinone oxidoreductase chain 1 | 0 | 2 | 0 | 2 |
| ras-related protein Rab-9A | 8 | 0 | 0 | 8 |
| Potassium channel subfamily K member 2 | 0 | 4 | 1 | 5 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 6 | 1 | 0 | 7 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 3 | 2 | 5 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 3 | 1 | 4 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 7 | 0 | 0 | 7 |
| Cocaine esterase | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
| Major prion protein | 0 | 0 | 2 | 2 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 4 |
| Mu-type opioid receptor | 0 | 5 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 4 subunit alpha | 0 | 4 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 5 subunit alpha | 0 | 5 | 0 | 5 |
| Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Protease | 0 | 3 | 0 | 3 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 11 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 8 subunit alpha | 0 | 3 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 3 | 0 | 3 |
| Chain E, Fibrin beta chain | 0 | 2 | 0 | 2 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| luciferase | 2 | 0 | 0 | 2 |
| CDK5 | 0 | 0 | 0 | 1 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 7 | 0 | 0 | 7 |
| Tat | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 2 | 0 | 0 | 2 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| Snq2p | 0 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Envelope glycoprotein | 0 | 0 | 2 | 2 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 3 | 1 | 4 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 3 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Alpha-mannosidase 2C1 | 0 | 1 | 0 | 1 |
| Fucose-binding lectin PA-IIL | 0 | 1 | 0 | 1 |
| CD209 antigen | 0 | 1 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 2 | 5 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 2 | 5 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 2 | 5 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 4 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
| Delta-type opioid receptor | 0 | 4 | 0 | 5 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 3 | 2 | 6 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Integrin beta | 0 | 0 | 1 | 1 |
| Glycoprotein IIb | 0 | 0 | 1 | 1 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| Type II pantothenate kinase | 0 | 0 | 0 | 1 |
| Type III pantothenate kinase | 0 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
| Cytochrome P450 2B6 | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 1 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 3 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| XBP1 | 0 | 1 | 0 | 1 |
| DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 3 | 3 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| WD repeat-containing protein 48 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Histamine H3 receptor | 0 | 0 | 0 | 1 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
| BRCA1 | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 3 | 0 | 3 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
| karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 2 | 0 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
| Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| Chain H, ALPHA-THROMBIN | 0 | 0 | 1 | 1 |
| Chain A, Transcriptional regulator qacR | 0 | 0 | 1 | 1 |
| Chain A, Transcriptional regulator qacR | 0 | 0 | 1 | 1 |
| Chain A, TETR FAMILY TRANSCRIPTIONAL REPRESSOR LFRR | 0 | 0 | 1 | 1 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Major pollen allergen Bet v 1-A | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 0 | 0 | 1 |
| Coagulation factor XII | 0 | 1 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Carbon monoxide dehydrogenase small chain | 0 | 0 | 1 | 1 |
| Dual specificity protein phosphatase 1 | 0 | 1 | 0 | 1 |
| M-phase inducer phosphatase 2 | 0 | 1 | 0 | 1 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Dual specificity protein phosphatase 6 | 0 | 1 | 0 | 1 |
| Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
| Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
| Beta-lactoglobulin | 0 | 0 | 1 | 1 |
| Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain C, DODECIN | 0 | 0 | 1 | 1 |
| Chain E, DODECIN | 0 | 0 | 1 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Riboflavin-binding protein | 0 | 1 | 1 | 2 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 2 | 3 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 4 | 0 | 5 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 6 |
| Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase (fumarate) | 0 | 1 | 0 | 1 |
| Acyl carrier protein, mitochondrial | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Stromelysin-1 | 0 | 1 | 1 | 2 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 14alpha-demethylase | 0 | 0 | 1 | 1 |
| Sterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Thromboxane A2 receptor | 0 | 0 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 2 |
| Peroxisome proliferator-activated receptor delta | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 1 | 3 | 4 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor delta | 0 | 1 | 1 | 2 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| P53 | 1 | 0 | 0 | 1 |
| Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
| Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 0 | 1 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain B, Odorant-binding Protein | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Secreted chorismate mutase | 0 | 1 | 0 | 1 |
| Heat sensitive channel TRPV3 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Transthyretin | 0 | 1 | 0 | 2 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 2 | 0 | 2 |
| Vasopressin V1a receptor | 0 | 2 | 0 | 2 |
| Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 0 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |